OptimizeRx (OPRX) Aktie Kurs

The business model of OPTIMIZERx Corp is focused on providing software solutions and technology platforms to the healthcare industry. The company offers a comprehensive suite of services, including electronic prescribing for healthcare providers, patient engagement and adherence tools, as well as financial assistance programs for patients to help them access and afford medication. OPTIMIZERx Corp's innovative technology enables pharmaceutical manufacturers to effectively engage with healthcare professionals and patients, improving patient outcomes and reducing healthcare costs. With its unique offerings and solutions, OPTIMIZERx Corp aims to optimize the connection between patients, healthcare providers, and pharmaceutical companies in the healthcare ecosystem.

OPTIMIZERx Corp is primarily active in the healthcare and pharmaceutical industries.

OPTIMIZERx Corp is a renowned digital health company that specializes in providing software solutions to streamline the pharmaceutical industry. Founded in 2006, OPTIMIZERx has established itself as a leader in the field, offering innovative platforms to enhance patient engagement and adherence. With a focus on improving communication between healthcare providers, pharmaceutical companies, and patients, OPTIMIZERx's solutions enable physicians to deliver cost-effective and personalized care. The company has consistently grown its presence by incorporating cutting-edge technologies and strategic partnerships, ensuring it stays at the forefront of the industry. OPTIMIZERx Corp's commitment to improving patient outcomes has made it a trusted name in the digital health sector.

OPTIMIZERx Corp, a leading provider of digital health communication solutions, has achieved several significant milestones. The company experienced impressive revenue growth, surpassing $30 million in annual revenue in 2020. In addition, OPTIMIZERx Corp expanded its client base, forging partnerships with renowned pharmaceutical manufacturers, healthcare providers, and pharmacies. The company launched innovative solutions, such as its SampleRx platform, which allows patients to access cost-saving coupons and trial offers for prescription medications. OPTIMIZERx Corp also made strategic acquisitions, augmenting its capabilities and expanding its market reach. These milestones demonstrate the company's commitment to revolutionizing patient engagement and improving prescription affordability in the healthcare industry.

OPTIMIZERx Corp is primarily present in the United States.

Optimizerx Corp represents values of innovation, collaboration, and customer-centricity. With a strong corporate philosophy focused on improving patient access to life-saving therapies, Optimizerx Corp aims to enhance the healthcare ecosystem through its digital platform and strategic partnerships. Committed to delivering superior solutions and services, the company leverages cutting-edge technology and data-driven insights to empower patients, healthcare providers, and pharmaceutical manufacturers. Optimizerx Corp strives to optimize the healthcare experience, driving better outcomes, cost-savings, and improved patient adherence. As a trusted leader in the industry, Optimizerx Corp demonstrates a dedication to excellence, integrity, and creating value for its shareholders, healthcare partners, and the overall community.

Analytikere sætter i øjeblikket et gennemsnitligt kursmål på 10,25 USD for OptimizeRx-aktien (median: 11,00 USD), svarende til +9,7 % i forhold til seneste kurs. Konsensus bygger på 12 analytikervurderinger.

OptimizeRx Analytikerens Kursmål 2026

12 analytikere vurderer i øjeblikket OptimizeRx-aktien: 11 anbefaler køb, 1 hold og 0 salg. For 2026 forventer analytikere, at OptimizeRx genererer omsætning på 96,23 Mio. USD og indtjening pr. aktie på 0,86 USD.

OptimizeRx Analytikerens Kursmål 2026

Omregnet til den aktuelle valutakurs handles OptimizeRx-aktien til 8,37 EUR (9,35 USD).

OptimizeRx-aktien (OPRX) er noteret på 1 børser, herunder: NASDAQ (OPRX).

The OPTIMIZERx Corp is a leading provider of digital solutions to improve patient communication, adherence, and access to medications. The company is headquartered in Rochester, Michigan and works with numerous pharmaceutical manufacturers, insurers, and pharmacies to optimize healthcare. One of OPTIMIZERx's main products is the Sample Fulfillment System (SFS), a paperless system for ordering and delivering medication samples to doctors. Doctors can access a wide range of medications, order samples, and effectively treat their patients through the system. The SFS is easy to use and provides doctors with a convenient way to receive medications and care for patients. OPTIMIZERx also offers a variety of patient communication solutions to improve compliance and adherence. The OPTIMIZERx portal is an online portal that allows patients to order and manage medications, as well as receive information about their medications and their side effects. The portal is user-friendly and easy to navigate, allowing patients to securely access their medical information. Another important area of OPTIMIZERx is supporting patients with coupons and discounts on prescription medications. OPTIMIZERx offers discount programs for a variety of medications to help patients manage the high costs of their medications. Similarly, OPTIMIZERx offers various options to assist patients in applying for discounts and ensuring they receive the best offer. In addition, OPTIMIZERx also provides communication solutions for pharmacies to improve information exchange and collaboration between pharmacies and doctors. The OPTIMIZERx eCoupon system allows pharmacies to pass on discounts and coupons directly to patients. In summary, the OPTIMIZERx Corp offers a wide range of digital solutions to improve patient communication, increase adherence and compliance, and facilitate access to medications. The company works closely with pharmaceutical manufacturers and other healthcare providers to optimize healthcare and provide the best possible support for patients.

forventet-omsætningen for OptimizeRx er 96,23 Mio. USD. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.

forventet-overskuddet for OptimizeRx er 16,71 Mio. USD. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.

Pris-til-indtjening-forholdet (P/E) for OptimizeRx er i øjeblikket 10,84. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af OptimizeRx-aktien.

Pris-til-salgs-forholdet (P/S) for OptimizeRx er i øjeblikket 1,88. P/S-forholdet sammenligner markedskapitalisering med årlig omsætning og fungerer som en værdiansættelsesmetrik for OptimizeRx-aktien.

AlleAktien-kvalitetsscore for OptimizeRx er 5/10.

ISIN for OptimizeRx er US68401U2042. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.

WKN for OptimizeRx er A2JL4Z. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.

Tickeren for OptimizeRx er OPRX. Tickersymbolet bruges til at handle OptimizeRx-aktier på børsen.